1. Home
  2. RS vs INAB Comparison

RS vs INAB Comparison

Compare RS & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Reliance Steel & Aluminum Co. (DE)

RS

Reliance Steel & Aluminum Co. (DE)

HOLD

Current Price

$392.65

Market Cap

19.4B

Sector

Industrials

ML Signal

HOLD

Logo IN8bio Inc.

INAB

IN8bio Inc.

HOLD

Current Price

$1.10

Market Cap

11.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RS
INAB
Founded
1939
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.4B
11.8M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
RS
INAB
Price
$392.65
$1.10
Analyst Decision
Buy
Strong Buy
Analyst Count
6
1
Target Price
$358.00
$6.00
AVG Volume (30 Days)
311.3K
59.6K
Earning Date
04-22-2026
05-11-2026
Dividend Yield
1.39%
N/A
EPS Growth
N/A
N/A
EPS
5.10
N/A
Revenue
$14,805,900,000.00
N/A
Revenue This Year
$10.16
N/A
Revenue Next Year
$0.82
N/A
P/E Ratio
$77.45
N/A
Revenue Growth
N/A
N/A
52 Week Low
$260.31
$0.88
52 Week High
$433.02
$2.73

Technical Indicators

Market Signals
Indicator
RS
INAB
Relative Strength Index (RSI) 44.13 46.57
Support Level $382.48 $0.92
Resistance Level $419.83 $1.50
Average True Range (ATR) 10.33 0.08
MACD -0.14 0.00
Stochastic Oscillator 36.96 39.71

Price Performance

Historical Comparison
RS
INAB

About RS Reliance Steel & Aluminum Co. (DE)

Reliance Inc operates a network of companies providing diversified metal solutions and is the metals service center company. It distributes a full line of over 100,000 metal products, including alloy, aluminum, brass, copper, carbon steel, stainless steel, titanium and other specialty steel products. The company services more than 125,000 customers in a variety of industries, including consumer products, general manufacturing, non-residential construction, transportation, aerospace, energy, electronics and semiconductor fabrication, industrial machinery and heavy industry. It also services the auto industry, through its toll processing operations where it processes customer-owned metal for a fee.

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma-delta T cells are a specialized population of T cells that possess properties. It has conducted two primary investigator-sponsored Phase 1 clinical trials evaluating its gamma-delta T cell technologies in cancer patients, which have both completed primary enrollment. INB-100 is assessing its DeltEx Allogeneic (Allo) gamma-delta T cell therapy in adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation (HSCT). It operates in a single segment.

Share on Social Networks: